Rituximab treatment of adults with primary focal segmental glomerulosclerosis
Crossref DOI link: https://doi.org/10.1038/s41598-023-33678-y
Published Online: 2023-04-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Liuwei
Yu, Lu
Wang, Yulin
Guo, Yanhong
Zhai, Zihan
Tang, Lin
Text and Data Mining valid from 2023-04-25
Version of Record valid from 2023-04-25
Article History
Received: 18 February 2023
Accepted: 17 April 2023
First Online: 25 April 2023
Competing interests
: The authors declare no competing interests.